Novelix Pharmaceuticals Inc Receives Patent for Betulinc Acid Derivative
Novelix Pharmaceuticals Inc Receives Patent for Betulinc Acid Derivative
About this item
Full title
Publisher
New Delhi: Athena Information Solutions Pvt. Ltd
Journal title
Language
English
Formats
Publication information
Publisher
New Delhi: Athena Information Solutions Pvt. Ltd
Subjects
More information
Scope and Contents
Contents
According to the Controller General of Patents, Designs & Trade Marks, "The present invention relates to novel betulinic acid derivatives with increased activity for the treatment of carcinomas and HIV diseases, a method for producing such novel betulinic acid derivatives as well as their use as pharmaceuticals."
Alternative Titles
Full title
Novelix Pharmaceuticals Inc Receives Patent for Betulinc Acid Derivative
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1013661622
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1013661622